ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,796,101 | -24.0% | 287,255 | -13.9% | 0.15% | -30.3% |
| Q2 2023 | $10,256,985 | -23.7% | 333,669 | -10.6% | 0.22% | -14.3% |
| Q1 2023 | $13,443,514 | -14.9% | 373,120 | -6.7% | 0.26% | -1.1% |
| Q4 2022 | $15,803,258 | -3.7% | 399,880 | -2.1% | 0.26% | -20.9% |
| Q3 2022 | $16,415,000 | -13.9% | 408,546 | -9.9% | 0.33% | -17.3% |
| Q2 2022 | $19,067,000 | +25.2% | 453,556 | +16.0% | 0.40% | +30.0% |
| Q1 2022 | $15,230,000 | +35.3% | 390,918 | +38.4% | 0.31% | +23.8% |
| Q4 2021 | $11,259,000 | +29.6% | 282,537 | +17.6% | 0.25% | +22.2% |
| Q3 2021 | $8,685,000 | -0.6% | 240,328 | +12.7% | 0.20% | +14.0% |
| Q2 2021 | $8,741,000 | +302.6% | 213,257 | +328.5% | 0.18% | +263.3% |
| Q1 2021 | $2,171,000 | – | 49,765 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |